First implantation of the pulsatile left ventricular assist device iVAC2L in a heart failure patient infected with influenza type A

Hellenic J Cardiol. 2021 Jul-Aug;62(4):326-328. doi: 10.1016/j.hjc.2020.05.002. Epub 2020 May 26.

Authors

S Tzikas¹, C H Papadopoulos², A P Evangeliou², V Vassilikos²

Affiliations

¹ 3rd Department of Cardiology, Ippokrateio General Hospital, Aristotle University of Thessaloniki, Greece. Electronic address: tzikas@gmail.com.
² 3rd Department of Cardiology, Ippokrateio General Hospital, Aristotle University of Thessaloniki, Greece.

PMID: 32470561
DOI: 10.1016/j.hjc.2020.05.002

No abstract available

Keywords: PulseCath iVAC2L; cardiogenic shock; heart failure; heart-assist devices; mechanical circulatory support.

Publication types

Case Reports

MeSH terms

Heart Failure*
Heart-Assist Devices* / adverse effects
Humans
Influenza, Human* / complications
Shock, Cardiogenic
Treatment Outcome